Investigations into Isoniazid Treated<i> Mycobacterium tuberculosis</i> by Electrospray Mass Spectrometry Reveals New Insights into Its Lipid Composition

<div>Comparison of the output obtained from MycoMass with that of Mtb LipidDB (MS-LAMP) for the “Control” and “INH-treated” MTB samples (see Section <a href="https://static.hindawi.com/articles/jpath/volume-2018/1454316/figures/#sec2.6">2.6</a>, Figure <a href="../fig3/">3</a>, and Table <a href="../tab6/">6</a>).</div>

Journal of Pathogens

fig6

Figure 6

Figure 6: Investigations into Isoniazid Treated<i> Mycobacterium tuberculosis</i> by Electrospray Mass Spectrometry Reveals New Insights into Its Lipid Composition 

Figure 6 | Investigations into Isoniazid Treated Mycobacterium tuberculosis by Electrospray Mass Spectrometry Reveals New Insights into Its Lipid Composition 